High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer

Conclusion: High DLL4 expression was observed in 19.9% of GC patients and was significantly associated with poor survival following curative surgery. Given its prevalence in the GC cohort with a poor prognosis, DLL4 is a potential therapeutic target.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Youjin Kim, Sun-ju Byeon, Joonyoung Hur, Kangkook Lee, Dongin Kim, Jin-Hyung Ahn, Sang Hoon Lee, Weon-Kyoo You, Seung Tae Kim, Se Hoon Park, Won Ki Kang, Kyoung-Mee Kim, Jeeyun Lee Tags: Research Paper Source Type: research